ol_ cowboy
@ol_cowboy
27 September, 10:28
Here it comes...Truth gonna slap Folks across the face.
Brace! Brace!
MURDER INC.
Recall on KILL DRUGS?
Bit late, and Doctors + Nurses watched it kill and still kept it going...
staying silent and distributing so as not to lose their paychecks.
NUREMBERG 2.0
"BREAKING: Gilead Sciences has issued a recall for its antiviral drug remdesivir, which showed a 53% mortality rate in clinical trials conducted in Africa."
https://t.me/toresaysPlus/...
Brace! Brace!
MURDER INC.
Recall on KILL DRUGS?
Bit late, and Doctors + Nurses watched it kill and still kept it going...
staying silent and distributing so as not to lose their paychecks.
NUREMBERG 2.0
"BREAKING: Gilead Sciences has issued a recall for its antiviral drug remdesivir, which showed a 53% mortality rate in clinical trials conducted in Africa."
https://t.me/toresaysPlus/...
Telegram: Contact @toresaysPlus
BREAKING: Gilead Sciences has issued a recall for its antiviral drug remdesivir, which showed a 53% mortality rate in clinical trials conducted in Africa. @GeneralMCNews
https://t.me/toresaysPlus/61740Notice: Undefined index: tg1tga_access in /home/admin/www/anonup.com/themes/default/apps/timeline/post.phtml on line 396
Royal Raven
@Royalraven
27 September, 10:31
In response ol_ cowboy to his Publication
Notice: Undefined index: tg1tga_access in /home/admin/www/anonup.com/themes/default/apps/timeline/post.phtml on line 396
(Adverse Reaction) Symptoms may include hypotension, hypertension, tachycardia, bradycardia, hypoxia, fever, dyspnea, wheezing, angioedema, rash, nausea, diaphoresis, and shivering. Slower infusion rates (maximum infusion time of up to 120 minutes) can potentially prevent these reactions. If a severe infusion-related hypersensitivity reaction occurs, immediately discontinue VEKLURY and initiate appropriate treatment
Administration should take place under conditions where management of severe hypersensitivity reactions, such as anaphylaxis, is possible.
Administration should take place under conditions where management of severe hypersensitivity reactions, such as anaphylaxis, is possible.
12:25 PM - Sep 27, 2024
In response Royal Raven to her Publication
Only people mentioned by Tallyho in this post can reply
